Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans

References

• AstraZeneca Crestor: Prescribing information
   Google Scholar
• Bi YA, Qiu X, Rotter CJ, et al. (2013). Quantitative assessment of the contribution of sodium-dependent taurocholate co-transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin. Biopharm Drug Dispos 34:452–61.
   PubMed Web of Science ®Google Scholar
• Bi YA, Scialis RJ, Lazzaro S, et al. (2017). Reliable rate measurements for active and passive hepatic uptake using plated human hepatocytes. AAPS J 19:796–882.
   Web of Science ®Google Scholar
• Black AE, Hayes RN, Roth BD, et al. (1999). Metabolism and excretion of atorvastatin in rats and dogs. Drug Metab Dispos 27:916–23.
   PubMed Web of Science ®Google Scholar
• Bleasby K, Castle JC, Roberts CJ, et al. (2006). Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 36:963–88.
   PubMed Web of Science ®Google Scholar
• Chen L, Pawlikowski B, Schlessinger A, et al. (2010). Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin. Pharmacogenet Genomics 20:687–99.
   PubMed Web of Science ®Google Scholar
• Choi MK, Shin HJ, Choi YL, et al. (2011). Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors. Xenobiotica 41:24–34.
   PubMed Web of Science ®Google Scholar
• Chu X, Bleasby K, Evers R. (2013). Species differences in drug transporters and implications for translating preclinical findings to humans. Expert Opin Drug Metab Toxicol 9:237–52.
   PubMed Web of Science ®Google Scholar
• Chu X, Shih SJ, Shaw R, et al. (2015). Evaluation of cynomolgus monkeys for the identification of endogenous biomarkers for hepatic transporter inhibition and as a translatable model to predict pharmacokinetic interactions with statins in humans. Drug Metab Dispos 43:851–63.
   PubMed Web of Science ®Google Scholar
• De Bruyn T, Sempels W, Snoeys J, et al. (2014). Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition. J Pharm Sci 103:1872–81.
   PubMed Web of Science ®Google Scholar
• Dong Z, Ekins S, Polli JE. (2013). Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP). Mol Pharm 10:1008–19.
   PubMed Web of Science ®Google Scholar
• Evers R, Chu XY. (2008). Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity. Mol Pharmacol 74:309–11.
   PubMed Web of Science ®Google Scholar
• Gotoh Y, Kato Y, Stieger B, et al. (2002). Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats. Am J Physiol Endocrinol Metab 282:E1245–54.
   PubMed Web of Science ®Google Scholar
• He YJ, Zhang W, Chen Y, et al. (2009). Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T > C polymorphism. Clin Chim Acta Int J Clin Chem 405:49–52.
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Lechon MJ, Houston JB, et al. (2007). Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39:159–234.
   PubMed Web of Science ®Google Scholar
• Higgins JW, Bedwell DW, Zamek-Gliszczynski MJ. (2012). Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics. Drug Metab Dispos 40:1170–7.
   PubMed Web of Science ®Google Scholar
• Ho RH, Tirona RG, Leake BF, et al. (2006). Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology 130:1793–806.
   PubMed Web of Science ®Google Scholar
• Hsiang B, Zhu Y, Wang Z, et al. (1999). A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem 274:37161–8.
   PubMed Web of Science ®Google Scholar
• International Transporter C, Giacomini KM, Huang SM, et al. (2010). Membrane transporters in drug development. Nat Rev Drug Discov 9:215–36.
   PubMed Web of Science ®Google Scholar
• Irving MG, Roll FJ, Huang S, Bissell DM. (1984). Characterization and culture of sinusoidal endothelium from normal rat liver: lipoprotein uptake and collagen phenotype. Gastroenterology 87:1233–47.
   PubMed Web of Science ®Google Scholar
• Ishigami M, Tokui T, Komai T, et al. (1995). Evaluation of the uptake of pravastatin by perfused rat liver and primary cultured rat hepatocytes. Pharm Res 12:1741–5.
   PubMed Web of Science ®Google Scholar
• Ito K, Chiba K, Horikawa M, et al. (2002). Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data? AAPS Pharm Sci 4:E25.
   PubMed Web of Science ®Google Scholar
• Ito K, Iwatsubo T, Kanamitsu S, et al. (1998). Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol Rev 50:387–412.
   PubMed Web of Science ®Google Scholar
• Izumi S, Nozaki Y, Komori T, et al. (2013). Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17beta-glucuronide, estrone-3-sulfate, and sulfobromophthalein. Drug Metab Dispos 41:1859–66.
   PubMed Web of Science ®Google Scholar
• Izumi S, Nozaki Y, Maeda K, et al. (2014). Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions. Drug Metab Dispos 43:235–47.
   PubMed Web of Science ®Google Scholar
• Jacobsen JK, Jensen B, Skonberg C, et al. (2011). Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocytes. Eur J Pharm Sci 44:427–36.
   PubMed Web of Science ®Google Scholar
• Jigorel E, Le Vee M, Boursier-Neyret C, et al. (2005). Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes. Drug Metab Dispos 33:1418–22.
   PubMed Web of Science ®Google Scholar
• Kotani N, Maeda K, Watanabe T, et al. (2011). Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes. Drug Metab Dispos 39:1503–10.
   PubMed Web of Science ®Google Scholar
• Lai Y, Mandlekar S, Shen H, et al. (2016). Coproporphyrins in plasma and urine can be appropriate clinical biomarkers to recapitulate drug-drug interactions mediated by organic anion transporting polypeptide inhibition. J Pharmacol Exp Ther 358:397–404.
   PubMed Web of Science ®Google Scholar
• Lau YY, Huang Y, Frassetto L, Benet LZ. (2007). Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clin Pharmacol Ther 81:194–204.
   PubMed Web of Science ®Google Scholar
• Liang D, Hagenbuch B, Stieger B, Meier PJ. (1993). Parallel decrease of Na(+)-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes. Hepatology 18:1162–6.
   PubMed Web of Science ®Google Scholar
• Lundquist P, Loof J, Sohlenius-Sternbeck AK, et al. (2014). The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions. Drug Metab Dispos 42:469–80.
   PubMed Web of Science ®Google Scholar
• Maeda K, Ikeda Y, Fujita T, et al. (2011). Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study. Clin Pharmacol Ther 90:575–81.
   PubMed Web of Science ®Google Scholar
• Maeda K, Sugiyama Y. (2010). The use of hepatocytes to investigate drug uptake transporters. Methods Mol Biol 640:327–53.
   PubMedGoogle Scholar
• Menochet K, Kenworthy KE, Houston JB, Galetin A. (2012). Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes. Drug Metab Dispos 40:1744–56.
   PubMed Web of Science ®Google Scholar
• Nezasa K, Takao A, Kimura K, et al. (2002). Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat. Xenobiotica 32:715–27.
   PubMed Web of Science ®Google Scholar
• Niemi M, Pasanen MK, Neuvonen PJ. (2006). SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin. Clin Pharmacol Ther 80:356–66.
   PubMed Web of Science ®Google Scholar
• Pfizer Lipitor prescribing information
   Google Scholar
• Prueksaritanont T, Chu X, Evers R, et al. (2014). Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin. Br J Clin Pharmacol 78:587–98.
   PubMed Web of Science ®Google Scholar
• Rippin SJ, Hagenbuch B, Meier PJ, Stieger B. (2001). Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology 33:776–82.
   PubMed Web of Science ®Google Scholar
• Rost D, Kopplow K, Gehrke S, et al. (2005). Gender-specific expression of liver organic anion transporters in rat. Eur J Clin Invest 35:635–43.
   PubMed Web of Science ®Google Scholar
• Sharma P, Holmes VE, Elsby R, et al. (2010). Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. Xenobiotica 40:24–37.
   PubMed Web of Science ®Google Scholar
• Shen H, Su H, Liu T, et al. (2015). Evaluation of rosuvastatin as an organic anion transporting polypeptide (OATP) probe substrate: in vitro transport and in vivo disposition in cynomolgus monkeys. J Pharmacol Exp Ther 353:380–91.
   PubMed Web of Science ®Google Scholar
• Shen H, Yang Z, Mintier G, et al. (2013). Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides: in vitro, in vivo, and in vitro-to-in vivo extrapolation. J Pharmacol Exp Ther 344:673–85.
   PubMed Web of Science ®Google Scholar
• Stieger B, Geier A. (2011). Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. Expert Opin Drug Metab Toxicol 7:411–25.
   PubMed Web of Science ®Google Scholar
• Swift B, Pfeifer ND, Brouwer KL. (2010). Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 42:446–71.
   PubMed Web of Science ®Google Scholar
• Tweedie D, Polli JW, Berglund EG, et al. (2013). Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter Consortium. Clin Pharmacol Ther 94:113–25.
   PubMed Web of Science ®Google Scholar
• Ulvestad M, Bjorquist P, Molden E, et al. (2011). OATP1B1/1B3 activity in plated primary human hepatocytes over time in culture. Biochem Pharmacol 82:1219–26.
   PubMed Web of Science ®Google Scholar
• Umehara K, Camenisch G. (2012). Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat. Pharm Res 29:603–17.
   PubMed Web of Science ®Google Scholar
• Varma MV, Lai Y, Kimoto E, et al. (2013). Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide. Pharm Res 30:1188–99.
   PubMed Web of Science ®Google Scholar
• Wang L, Prasad B, Salphati L, et al. (2015). Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics. Drug Metab Dispos 43:367–74.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zheng M, Leil T. (2017). Investigating transporter-mediated drug-drug interactions using a physiologically based pharmacokinetic model of rosuvastatin. CPT Pharmacometrics Syst Pharmacol 6:228–38.
   PubMedGoogle Scholar
• Watanabe T, Kusuhara H, Maeda K, et al. (2010). Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans. Drug Metab Dispos 38:215–22.
   PubMed Web of Science ®Google Scholar
• Xia CQ, Milton MN, Gan LS. (2007). Evaluation of drug-transporter interactions using in vitro and in vivo models. Curr Drug Metab 8:341–63.
   PubMed Web of Science ®Google Scholar
• Yan H, Zhong G, Xu G, et al. (2012). Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049.
   PubMed Web of Science ®Google Scholar
• Yang Q, Doshi U, Li N, Li AP. (2012). Effects of culture duration on gene expression of P450 isoforms, uptake and efflux transporters in primary hepatocytes cultured in the absence and presence of interleukin-6: implications for experimental design for the evaluation of downregulatory effects of biotherapeutics. Curr Drug Metab 13:938–46.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Maeda K, Sugiyama Y. (2012). Transporter-mediated drug-drug interactions involving OATP substrates: predictions based on in vitro inhibition studies. Clin Pharmacol Ther 91:1053–64.
   PubMed Web of Science ®Google Scholar
• Zamek-Gliszczynski MJ, Lee CA, Poirier A, et al. (2013). ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans. Clin Pharmacol Ther 94:64–79.
   PubMed Web of Science ®Google Scholar
• Zhang W, Deng S, Chen XP, et al. (2008). Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover study. Clin Ther 30:1283–9.
   PubMed Web of Science ®Google Scholar